
Single-use technologies have gained broad acceptance in biomanufacturing within the past few years, supporting flexible and cost-effective clinical production.
Dethardt Müller is vice-president, Technology Development, at Rentschler Biotechnologie GmbH.

Published: August 1st 2014 | Updated: